PRODUCT FEATURES
- Rhinozyn® has 3 randomized clinical trials published reporting improvements in a total of 305 subjects treated;
- The results shows a significant reduction of clinical symptoms of perennial rhinitis
- Compelling improvement of quality of life (RQLQ) in seasonal rhinitis
- Helps stimulating the Th1 immune response and reducing IgE synthesis
- The addiction of Vitamin D help modulates the immune response and is associated with aeroallergen sensitization and allergic rhinitis;
- Is the product with highest clinical efficacy amongst probiotic treatments for allergic rhinitis.
Overall conclusion:
- Significant evidence of beneficial clinical effects of Rhinozyn® in the treatment of allergic rhinitis;
- Adjunctive therapy with Rhinozyn® can be recommended for the treatment of allergic rhinitis;
- Meta-analysis proves Rhinozyn® to be the leading probiotic treatment for allergic rhinitis.